EPN-37PAEDIATRIC SPINAL EPENDYMOMA IN CANADA: A MULTICENTRE RETROSPECTIVE STUDY

Autor: Anne-Sophie Carret, Uri Tabori, Beverly Wilson, Daniel McNeely, Donna L. Johnston, Tamir Ailon, Christopher Dunham, Juliette Hukin, Paul Steinbok, Sylvia Cheng, Katrin Scheinemann, Bjorn Baadjes, J.E. Potts, David D. Eisenstat, Shayna Zelcer, Karen Goddard
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Popis: EPN-37. PAEDIATRIC SPINAL EPENDYMOMA IN CANADA: A MULTICENTRE RETROSPECTIVE STUDY Bjorn Baadjes1, Sylvia Cheng1, Paul Steinbok1, Jim Potts1, Karen Goddard2, Tamir Ailon3, Uri Tabori4, Anne-Sophie Carret5, Daniel McNeely6, David Eisenstat7, Beverly Wilson7, Donna Johnston8, Shayna Zelcer9, Katrin Scheinemann10, Christopher Dunham1, and Juliette Hukin1; British Columbia Children’s Hospital, Vancouver, BC, Canada; British Columbia Cancer Agency, Vancouver, BC, Canada; Vancouver Hospital and Health Sciences Centre, Vancouver, BC, Canada; The Hospital for Sick Children, Toronto, ON, Canada; Sainte-Justine Hospital, Montreal, QC, Canada; IWK Health Centre, Halifax, NS, Canada; Stollery Children’s Hospital, Edmonton, AB, Canada; Children’s Hospital of Eastern Ontario, Ottawa, ON, Canada; Children’s Hospital of Western Ontario, London, ON, Canada; The University Hospital Munster, Munster, NRW, Germany BACKGROUND: Ependymomas in children are predominantly located intracranially, with spinal cord ependymomas being rare. Our objective was to determine long-term outcomes of our Canadian paediatric cohort with spinal ependymoma. METHODS: This retrospective multicentre study analysed diagnosis, treatment and outcome of spinal ependymoma patients treated at 9 paediatric oncology centres in Canada between 1986 and 2006. RESULTS: Thirty-six children (20 male), median age 11.9 years (interquartile range 9.1 to 14.4 years), were identified. Length of follow-up was 72.8 months (34.6 to 108.4 months). Thirty-one patients (86%) had WHO grade I disease (all myxopapillary ependymoma located in cauda equina), while 5 (14%) had WHO grade 2 disease. Twenty-fiveof 36 patients (69%) underwent gross total resection (GTR) of tumour, with 11/36 (31%) patients having incomplete resections. Six patients received focal adjuvant radiation therapy. Twelve of 36 (33%) relapsed, with a median time to relapse of 27 months. Six of 25 patients (24%) with GTR relapsed, while 6/11 (55%) patients with incomplete resectionrelapsed.Amongrelapsedpatients, 9underwent further surgery (4GTR,4 incomplete resection, 1 unknown) and 8 had adjuvant radiation therapy. There was no statistical difference in WHO grade and whether adjuvant radiation therapy was administered at diagnosis between relapse and non-relapse patients. Seventeen patients (47%) were disease-free, 18 (50%) were alive with disease, and tumour status on one patient was unknown. One patient died of the disease. CONCLUSIONS: Spinal ependymoma in children is rare, but overall survival outcomes are excellent despite some children suffering recurrence. Neuro-Oncology 18:iii30–iii39, 2016. doi:10.1093/neuonc/now070.36 #The Author(s) 2016. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Databáze: OpenAIRE